COMBINATION THERAPY FOR MUSCULOSKELETAL DISEASES WITH TOPICAL IBUPROFEN FORMULATIONS

Download full text PDF
Issue: 
6
Year: 
2017

T. Sakovets (1, 2), Candidate of Medical Sciences; G. Khuzina (1, 2), Candidate of Medical Sciences; A. Emelin (1, 2), Candidate of Medical Sciences 1-Kazan State Medical University 2-«Pozvonochnik» (Spine) Medical Center, Kazan

The topical application of ibuprofen (Dolgit®) as cream and gel provides an optimal drug concentration in the adjacent tissues in the immediate vicinity of a pathological focus, which is most important in musculoskeletal injuries (bruises, sprains of the capsular-ligament apparatus) and in patients with postoperative bone and joint diseases, which allows the drug to be recommended for the combination treatment of musculoskeletal diseases and injuries in individuals of different age groups.
Keywords: 
rheumatology
traumatology
osteoarthritis
musculoskeletal diseases and injuries
ibuprofen
Dolgit® cream
Dolgit® gel

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Goldring M., Otero M. Inflammation in osteoarthritis // Curr. Opin. Rheumatol. – 2011; 23 (5): 471–8.
  2. Song I., Burmester G., Backhause M. et al. Knee osteoarthritis. Efficacy of a new method of contrast – enhanced musculoskeletal ultrasonography in detection of synovitis in patients with knee osteoarthritis in comparison with magnetic resonance imaging // Ann. Rheum. Dis. – 2008; 1 (67): 19–25.
  3. Scanzello C., Moskowitz N., Gibofsky A. The post-NSAID era: what to use now for the pharmacologic treatment of pain and inflammation in osteoarthritis // Curr. Rheumatol. Rep. – 2008; 10 (1): 49–56.
  4. Wolfe F., Zhao S., Lane N. Preference for nonsteroidal antiinflammatory drugs over acetaminophen by rheumatic disease patients: a survey of 1,799 patients with osteoarthritis, rheumatoid arthritis, and fibromyalgia // Arthritis Rheum. – 2000; 43 (2): 378–85.
  5. Badokin V.N. Znachenie lokal'noj terapii NPVP v klinicheskoj praktike // Farmakologija. – 2012; 4: 81–5.
  6. Bruyere O., Cooper C., Pelletier J. et al. An algorithm recommendation for the management of knee osteoarthritis in Europe andinternationally: A report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) // Semin Arthritis Rheum. – 2014; 44 (3): 253–63.
  7. Vruyere O., Cooper C., Pelletier J. et al. A consensus statement on the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) Algorithm for the management of knee osteoarthritis – From evidence-based medicine to the real-life setting // Semin Arthritis Rheum. – 2016; 45 (4 Suppl.): 3–11.
  8. Bierma S., Brewz J., Wilsonx R. et al. A new lipid formulation of low dose (1200mg) ibuprofen is non-inferior to high dose (2400 mg) standard ibuprofen capsules in man a gingepisodic knee pain flares Abstracts // Osteoarthritis and Cartilage. – 2017; 25: 76–444.
  9. GUIDELINE American Geriatrics Society 2015 updated Beers Criteria for potentially inappropriate medication use in older adults // J. Am. Geriatr. Soc. – 2015; 63 (11): 2227–46.
  10. Alekseeva L.I. Lokal'naja terapija osteoartroza // Nauch.-prakt. revmatol. – 2006; 2: 22–30.
  11. Denisov L.N., Prozorovskaja Z.A., Ivanova O.N. i dr. Povyshaet li kombinatsija nesteroidnyh protivospalitel'nyh preparatov i mentola effektivnost' lokal'noj terapii? // Nauch.-prakt. revmatol. – 2006; 1: 34–9.
  12. Tsvetkova E.S., Alekberova Z.S, Balabanova R.M. i dr. Mnogotsentrovaja otsenka effektivnosti i perenosimosti lokal'noj terapii kremom «Dolgit» u bol'nyh osteoartrozom // Ter. arh. – 1995; 6: 48–50.
  13. Chichasova N.V. Lokal'naja terapija hronicheskih zabolevanij oporno-dvigatel'nogo apparata // Rus. med. zhurn. – 2001; 9 (7–8): 286–8.
  14. Zhang W., Nuki G., Moskowitz R. et al. OARSI recommendations for the management of hip and knee osteoarthritis. Part III: changes in evidence following systematic cumulative update of research published through January 2009 // Osteoartr. Cartil. – 2010; 18: 476–99.
  15. Revmatologija: klinicheskie rekomendatsii. Pod red. E.L. Nasonova / M.: GEOTAR-Media, 2010; 752 s.
  16. Alekseeva L.I. Mesto lokal'noj terapii v lechenii osteoartroza // Hirurgija. RMZh. – 2011; 32: 2048–51.
  17. Lin J., Zhang W., Jones A. et al. Efficacy of topical NONSteroidal anti-inflammatory drugs in the treatment of osteoarthritis: meta-analysis of randomized controlled trials // BMJ. – 2004; 329: 324–6.
  18. Barkin R. Topical Nonsteroidal Anti-Inflammatory Drugs: The Importance of Drug, Delivery, and Therapeutic Outcome // Am. J. Ther. – 2015; 22 (5): 388–407.
  19. Trnavský K., Fischer M., Vögtle-Junkert U. et al. Efficacy and safety of 5% ibuprofen cream treatment in knee osteoarthritis. Results of a randomized, double-blind, placebo-controlled study // J. Rheumatol. – 2004; 31 (3): 565–72.
  20. Rovenský J., Miceková D., Gubzová Z. et al. Treatment of knee osteoarthritis with a topical non-steroidal antiinflammatory drug. Results of a randomized, double-blind, placebo-controlled study on the efficacy and safety of a 5% ibuprofen cream // Drugs Exp. Clin. Res. – 2001; 27 (5–6): 209–21.
  21. Berner G., Engels B., Vögtle-Junkert U. Percutaneous ibuprofen therapy with Trauma-Dolgit gel: bioequivalence studies // Drugs Exp. Clin. Res. – 1989; 15 (11–12): 559–64.
  22. Giese U. Absorption and distribution of ibuprofen from a cream formulation after dermal administration to guinea pigs // Arzneimittelforschung. – 1990; 40 (1): 84–8.
  23. Rovenský J., Svík K., Istok R. et al. Quantitative assessment of markers of inflammation, arthritis and pain in rats with adjuvant arthritis following the treatment with ibuprofen cream and placebo // Drugs Exp. Clin. Res. – 2003; 29 (2): 85–90.
  24. Zgoda M., Kołodziejska J., Nachajski M. Viscosity of hydrogel pharmaceutical products and the rate of diffusion of ibuprofen hydrotropic binding through model phase boundary in vitro // Polim. Med. – 2007; 37 (1): 3–24.
  25. Stahl J., Wohlert M., Kietzmann M. The effect of formulation vehicles on the in vitro percutaneous permeation of ibuprofen // BMC Pharmacol. – 2011; 11: 12.
  26. Campbell J., Dunn T. Evaluation of topical ibuprofen cream in the treatment of acute ankle sprains // J. Accid. Emerg. Med. – 1994; 11 (3): 178–82.
  27. Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 // Lancet. – 2015; 386 (9995): 743–800.
  28. Nalamachu S. An overview of pain management: the clinical efficacy and value of treatment // Am. J. Manag. Care. – 2013; 19 (14 suppl.): 261–6.
  29. Derry S., Moore R., Gaskell H. et al. Topical NSAIDs for acute musculoskeletal pain in adults // Cochrane Database Syst. Rev. – 2015; 6: CD007402.
  30. McCarberg B., D'Arcy Y. Options in topical therapies in the management of patients with acute pain // Postgrad. Med. – 2013; 125 (4 Suppl. 1): 19–24.
  31. Nielsen L., Drewes A., Svendsen L. et al. Quantitative assessment of joint pain following treatment of rheumatoid arthritis with ibuprofen cream Arendt // Scand. J. Rheumatol. – 1994; 23 (6): 334–7.
  32. Ross S. Osteoarthritis: a proprietary Arnica gel is found to be as effective as ibuprofen gel in osteoarthritis of the hands // Holist. Nurs. Pract. – 2008; 22 (4): 237–9.
  33. Ambler J., Zideman D., Deakin C. The effect of topical non-steroidal anti-inflammatory cream on the incidence and severity of cutaneous burns following external DC cardioversion // Resuscitation. – 2005; 65 (2): 173–8.
  34. Machen J., Whitefield M. Efficacy of a proprietary ibuprofen gel in soft tissue injuries: a randomised, double-blind, placebo-controlled study // Int. J. Clin. Pract. – 2002; 56 (2): 102–6.
  35. Whitefield M., O’Kane C., Anderson S. Comparative efficacy of a proprietary topical ibuprofen gel and oral ibuprofen in acute soft tissue injuries: a randomized, double-blind study // J. Clin. Pharm. Ther. – 2002; 27 (6): 409–17.
  36. Tiso R., Tong-Ngork S., Fredlund K. Oral versus topical ibuprofen for chronic knee pain: a prospective randomized pilot study // Pain Physician. – 2010; 13 (5): 457–67.
  37. Argoff C. Topical Analgesics in the Management of Acute and Chronic Pain // Mayo Clin. Proc. – 2013; 88 (2): 195–205.
  38. Elfimov A.A. Mestnoe primenenie ibuprofena pri travmah i zabolevanijah oporno-dvigatel'nogo apparata // Vrach. – 2016; 11: 58–9.
  39. Hamrabaeva F.I. Sravnitel'naja otsenka iono- i fonoforeza s kremom «Dolgit» u patsientov s revmatoidnym artritom // Gastroenterologija Sankt-Peterburga. – 2016; 1–2: 35–6.
  40. Tkachenko K.G. Efirnomaslichnye rastenija i efirnye masla: dostizhenija i perspektivy, sovremennye tendentsii izuchenija i primenenija // Vestn. Udmurtskogo universiteta. – 2011; 1: 80–100.